[G24-31] Cefepime/enmetazobactam (bacterial infections, several therapeutic indications) – Addendum to Project G24-15
Last updated 05.12.2024
Project no.:
G24-31
Commission:
Commission awarded on 29.10.2024 by the Federal Joint Committee (G-BA).
Report type:
Addendum
Status:
Commission completed
Department/Division:
Health Economics
Topic:
Immune system and infections
Note:
If, in the course of the discussions on a commission of the G-BA, a need for further revision arises, IQWiG presents its report in the form of an addendum. The G-BA decides on the number of patients in the SHI target population.
DOI:
https://doi.org/10.60584/G24-31
| Project no. | Title | Status |
|---|---|---|
| G24-15 | Cefepime/enmetazobactam (bacterial infections, several therapeutic indications) – Assessment according to §35a (para. 1c) Social Code Book V | Commission completed |
Federal Joint Committee (G-BA)
2024-12-05 A G-BA decision was published.